@article{7c7fd12a649f4cf7b5e2c5875f919e16,
title = "Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level",
abstract = "The human microbiome encodes extensive metabolic capabilities, but our understanding of the mechanisms linking gut microbes to human metabolism remains limited. Here, we focus on the conversion of cholesterol to the poorly absorbed sterol coprostanol by the gut microbiota to develop a framework for the identification of functional enzymes and microbes. By integrating paired metagenomics and metabolomics data from existing cohorts with biochemical knowledge and experimentation, we predict and validate a group of microbial cholesterol dehydrogenases that contribute to coprostanol formation. These enzymes are encoded by ismA genes in a clade of uncultured microorganisms, which are prevalent in geographically diverse human cohorts. Individuals harboring coprostanol-forming microbes have significantly lower fecal cholesterol levels and lower serum total cholesterol with effects comparable to those attributed to variations in lipid homeostasis genes. Thus, cholesterol metabolism by these microbes may play important roles in reducing intestinal and serum cholesterol concentrations, directly impacting human health.",
keywords = "Clostridium cluster IV, Framingham Heart Study, cholesterol, coprostanol, hydroxysteroid dehydrogenase, metabolomics, metagenomic species, metagenomics, microbial dark matter, microbiome",
author = "Kenny, {Douglas J.} and Plichta, {Damian R.} and Dmitry Shungin and Nitzan Koppel and Hall, {A. Brantley} and Beverly Fu and Vasan, {Ramachandran S.} and Shaw, {Stanley Y.} and Hera Vlamakis and Balskus, {Emily P.} and Xavier, {Ramnik J.}",
note = "Funding Information: We thank Tiffany Poon, Luke Besse, and Sara Garamszegi for project management of sample processing and data handling. We also thank the Broad Institute Microbial {\textquoteleft}Omics Core for help with sequencing data generation. We would like to thank Dr. Paul D. Boudreau and Dr. Benjamin M. Woolston for critical advice in analysis of sterols by mass spectrometry. We are grateful to Heather Kang for editorial assistance with the manuscript and figures. This research was supported by funding from the Center for Microbiome Informatics and Therapeutics (award 6932308 PO# 5710003938) to R.J.X.; NIH (P30 DK043351) to R.J.X.; NIH (5 R01 HL131015-04) to S.Y.S. R.J.X. and R.S.V.; David and Lucille Packard Foundation (2013-39267) to E.P.B.; and Bill & Melinda Gates Foundation (OPP1158186) to E.P.B. S.Y.S. receives support from the One Brave Idea Award from the American Heart Association. D.S. was supported by the Swedish Research Council International Career Fellowship (4.1-2016-00416). R.S.V. is supported in part by the Evans Medical Foundation and the Jay and Louis Coffman Endowment from the Department of Medicine, Boston University School of Medicine. N.K. is supported by the Smith family (graduate science and engineering fellowship), the National Science Foundation (Graduate Research Fellowship, DGE1144152), and the National Institutes of Health (training grant, GM095450-01). B.F. is supported by the National Science Foundation (Graduate Research Fellowship, DGE1144152). The Framingham heart study (FHS) acknowledges the support of contracts NO1-HC-25195, HHSN268201500001I, 75N92019D00031, 75N92019D00031, and R01HL131015 (PIs S.Y.S. R.J.X. and R.S.V.) from the National Heart Lung and Blood Institute and grant supplement R01 HL092577-06S1 for this research. We also acknowledge the dedication of the FHS study participants without whom this research would not be possible. D.J.K. H.V. E.P.B. and R.J.X. conceived of the project. D.J.K. N.K. and B.F. performed the biochemical experiments. D.J.K. performed culture-based experiments and analysis by mass spectrometry. D.R.P. analyzed sequencing data from culture-based experiments and performed bioinformatics analyses of stool metagenomic data from human cohorts. D.R.P. assembled and analyzed high-quality genomes for IsmA enzyme-encoding species. D.S. performed association analysis of stool metabolomics and serum lipids with IsmA homolog status. A.B.H. sequenced, assembled, and annotated the E. coprostanoligenes genome. R.S.V. and S.Y.S. provided samples from the FHS cohort. H.V. and R.J.X. generated metagenomic data for the FHS cohort. D.J.K. D.R.P. D.S. H.V. R.J.X. and E.P.B. provided critical feedback on experiments. D.J.K. D.R.P. D.S. H.V. R.J.X. and E.P.B. wrote the manuscript. E.P.B. has consulted for Merck, Novartis, and Kintai Therapeutics. She is on the Scientific Advisory Boards of Kintai Therapeutics and Caribou Biosciences and is an Institute Member of the Broad Institute of MIT and Harvard. R.J.X. is a consultant to Novartis and Nestle. Funding Information: We thank Tiffany Poon, Luke Besse, and Sara Garamszegi for project management of sample processing and data handling. We also thank the Broad Institute Microbial {\textquoteleft}Omics Core for help with sequencing data generation. We would like to thank Dr. Paul D. Boudreau and Dr. Benjamin M. Woolston for critical advice in analysis of sterols by mass spectrometry. We are grateful to Heather Kang for editorial assistance with the manuscript and figures. This research was supported by funding from the Center for Microbiome Informatics and Therapeutics (award 6932308 PO# 5710003938 ) to R.J.X.; NIH ( P30 DK043351 ) to R.J.X.; NIH ( 5 R01 HL131015-04 ) to S.Y.S., R.J.X., and R.S.V.; David and Lucille Packard Foundation ( 2013-39267 ) to E.P.B.; and Bill & Melinda Gates Foundation ( OPP1158186 ) to E.P.B. S.Y.S. receives support from the One Brave Idea Award from the American Heart Association. D.S. was supported by the Swedish Research Council International Career Fellowship ( 4.1-2016-00416 ). R.S.V. is supported in part by the Evans Medical Foundation and the Jay and Louis Coffman Endowment from the Department of Medicine, Boston University School of Medicine . N.K. is supported by the Smith family (graduate science and engineering fellowship), the National Science Foundation ( Graduate Research Fellowship, DGE1144152 ), and the National Institutes of Health (training grant, GM095450-01 ). B.F. is supported by the National Science Foundation (Graduate Research Fellowship, DGE1144152 ). The Framingham heart study (FHS) acknowledges the support of contracts NO1-HC-25195 , HHSN268201500001I , 75N92019D00031 , 75N92019D00031 , and R01HL131015 (PIs S.Y.S., R.J.X., and R.S.V.) from the National Heart Lung and Blood Institute and grant supplement R01 HL092577-06S1 for this research. We also acknowledge the dedication of the FHS study participants without whom this research would not be possible. Publisher Copyright: {\textcopyright} 2020 The Authors",
year = "2020",
month = aug,
day = "12",
doi = "10.1016/j.chom.2020.05.013",
language = "English (US)",
volume = "28",
pages = "245--257.e6",
journal = "Cell Host and Microbe",
issn = "1931-3128",
publisher = "Cell Press",
number = "2",
}